sion exhibited a higher potential for differentiation toward osteogenic and adipogenc cell lineages in vitro when compared to a mixed population. Interestingly, SSEA-4 expression was lost upon differentiation, suggesting that the antigen marks a subpopulation of MSCs. Taken together, the data demonstrate that breast adipose tissue is highly enriched in a subpopulation of MSCs expressing SSEA-4 and suggest that SSEA-4 may be a marker of a subpopulation of MSCs with high potential for osteogenic and adipogenic differentiation. 
Introduction
Mesenchymal stem cells (MSCs) or multipotent mesenchymal stromal cells have generated interest and excitement because of the potential they hold in regenerative medicine. The cells are present in many tissues, particularly bone marrow, muscle, fat, and other tissues [Pittenger et al., 1999; Gronthos et al., 2000; Lee et al., 2000; Zuk et al., 2001; De Bari et al., 2003; Bi et al., 2007] . The most studied MSCs are those harvested from bone marrow; although adipose tissue has been shown to be an abundant source of these cells, it has received less attention. Adipose tissue is an attractive source of MSCs because it is plentiful and easy to obtain compared to most other types of mesenchymal tissues. Apart from their ease of isolation, adipose-derived stem cells (ADSCs) and bone marrow-derived MSCs (BMSCs) do not possess any major differences; however, minor differences have been noted [Gimble et al., 2007; Yoshimura et al., 2007; Merceron et al., 2010; Niemeyer et al., 2010] .
There are no established specific markers available for the identification of MSCs; thus MSCs are characterized in part by cell surface markers that are also expressed by other cell types with no stem cell characteristics [Chamberlain et al., 2007; Docheva and Schieker, 2008; Alison and Islam, 2009; Maddox et al., 2009] . Some of the surface markers that identify MSCs include: CD49a, CD90, CD105, CD146, CD271, and STRO-1 among many others [Chamberlain et al., 2007; Crisan et al., 2008; Docheva and Schieker, 2008; Alison and Islam, 2009; Maddox et al., 2009; Halfon et al., 2010] . These markers serve as a guide for characterizing MSCs harvested from various tissues.
Stage-specific embryonic antigen-4 (SSEA-4) is an early embryonic globoseries glycolipid antigen which is commonly used to identify human embryonic stem cells (ESCs) [Carpenter et al., 2003] . This antigen has also been found to be expressed by MSCs, testicular germ cells, and aggressive cancer cell lines such as renal and breast cancer [Saito et al., 1991 [Saito et al., , 2003 Gang et al., 2007; Villadsen et al., 2007; Muller et al., 2008; Charafe-Jauffret et al., 2009; Gonzalez et al., 2009] . The first report on SSEA-4 as a maker for MSC was by Perlingeiro and colleagues [Gang et al., 2007] . The authors reported that SSEA-4-positive cells were present in murine marrow and represented 1-2% of the cell population at day 0 of cell isolation. Similarly the authors reported that, in humans, SSEA-4+ cells comprised 2-4% of the cell population at day 0. The authors reported that the levels of cells expressing SSEA-4 increased with culturing reaching 78% of the cell population at day 21. The authors utilized SSEA-4 to isolate a homogenous population of multipotent BMSCs and demonstrated that cells expressing this antigen exhibited multipotent differentiation [Gang et al., 2007] . The authors concluded that SSEA-4 could prospectively be used to isolate MSCs from a mixed population of cells. The authors, however, did not examine the uniqueness of the cells expressing this antigen in comparison to the mixed population. Since this report, few studies have followed expression of this antigen by cells harvested from other mesenchymal tissues.
A number of clinical trials are currently under way to assess the effectiveness of ADSCs in treating various pathological conditions. Some of these conditions include breast augmentation and reconstruction and immune-related diseases, e.g. Crohn's disease [Gimble et al., 2011] . The outcomes of these clinical trials remain to be evaluated.
In the present investigation, we set out to determine the level of SSEA-4-expressing cells in preparations from adipose tissues and asked whether SSEA-4 could be considered a universal marker for the identification of MSCs. We also determined osteogenic and adipogenic differentiation of cells enriched in SSEA-4 expression and the mixed population. We report here that adipose tissue is enriched in cells expressing SSEA-4, especially cells in breast adipose tissue. The cells expressing this antigen exhibit a higher potential to differentiate into osteogenic and adipogenic cell lineages in vitro when compared to the mixed population. In contrast to the report by Gang et al. [2007] for cells in bone marrow and SSEA-4 expression, breast adipose tissue appeared to be enriched in a population of cells expressing this antigen at day 0 of isolation and its expression remained relatively constant.
Materials and Methods

Isolation of the ADSCs
ADSCs were isolated from female (ages 57-64) breast and abdominal adipose tissues. Breast adipose was obtained from patients undergoing breast reduction, and abdominal fat was obtained from patients undergoing gastric bypass. In each case, fat was harvested from 3 patients; however, breast and abdominal adipose tissues were not harvested from the same patients but were of relatively close age ranges (57-64 years). To isolate cells, adipose tissues were minced, washed extensively in sterile PBS (Invitrogen, Carisbad, Calif., USA), and digested with 0.075% type II collagenase (Worthington, Lakewood, N.J., USA) at 37 ° C for 30 min with gentle agitation as described previously [Zuk et al., 2001; Liao et al., 2008; Maddox et al., 2009] . The digested fat was centrifuged at 2,000 rpm for 10 min. The pellet was washed repeatedly with PBS and then passed through a 70-m mesh filter. The filtrate was centrifuged as described above and plated onto type I collagen-coated tissue culture plates in DMEM (Invitrogen) supplemented with 10% FBS and 1% penicillin/streptomycin (P/S) v/v (all from Invitrogen) and incubated at 37 ° C in 5% CO 2 . Adipose tissue was obtained from 3 female patients in each case.
Flow Cytometry
The isolated cells were incubated with PE-labeled antibodies against CD45 and CD49a (BD Bioscience), and primary antibodies specific for SSEA-4 (Developmental Studies Hybridoma Bank, Iowa City, Iowa, USA), CD105 (endoglin; eBioscience, San Diego, Calif., USA), and CD146 (MelCAM; Santa Cruz, Santa Cruz, Calif., USA) followed by incubation with secondary antibodies conjugated to PE-Cy5 (goat anti-mouse IgG PE-Cy5 conjugate; Santa Cruz). Cells were incubated with the respective antibodies at a concentration of 20 g/ml. The expression level of each antigen was assessed by flow cytometry. Three trials were completed for each marker; each trial was run in triplicate.
Sorting for SSEA-4-Expressing Cells with a Magnetic Cell Sorting System
Since the focus was on cells isolated from breast adipose tissue, cells (ADSCs) isolated from breast adipose tissues were sorted for SSEA-4 by a Magnetic Cell Sorting System (MACS; Miltenyi Biotec, Auburn, Calif., USA). Cells were incubated at 4 ° C for 30 min with SSEA-4 antibody at a concentration of 20 g/ml. The cells were washed and then incubated at 4 ° C for 15 min with MACS MicroBeads (20 ml/10 7 cells). Cells were washed, resuspended in 500 l of MACS buffer, and then added to the magnetized MACS MS magnetic column. The unlabeled cells passed through and were collected. The column was removed from the separation magnet; labeled cells passed through and were collected. The collected labeled cell fraction was resorted for further enrichment into cells expressing SSEA-4. The cells were then plated and expanded in culture.
Immunocytochemistry Cells (1 ! 10 3 cells) were plated in 8-well chamber slides and allowed to expand to 80% confluence. The wells were washed and then fixed in ice-cold methanol/acetone (1: 1) for 30 min at -20 ° C. Next, the cells were permeabilzed by washing with 0.1% Tween/ PBS (Fisher, Pittsburgh, Pa., USA) 2 times. Then cells were blocked with 1% goat serum/PBS (Sigma-Aldrich, St. Louis, Mo., USA) for 1 h at room temperature. The cells were washed 2-4 times with PBS. Primary SSEA-4 antibody in 1% goat serum/PBS was added overnight at 4 ° C. Cells were then washed 2-4 times with PBS. A secondary PE-Cy5 antibody (Santa Cruz) in 1% goat serum/PBS was added for 20 min. Cells were washed, and then the slide was viewed under a light microscope. In some experiments visualization was achieved by a secondary antibody conjugated to FITC, and cells were also stained with DAPI for nuclei.
Differentiation Assays
Alkaline Phosphatase Activity Assay Cells cultured in DMEM supplemented with 10 -7 M dexamethasone (Sigma, St. Louis, Mo., USA) and 2 ! 10 -8 M 2-ascorbate (Sigma) were treated with 100 ng/ml of rhBMP-2 (Fitzgerald Industries, Acton, Mass., USA) for 3 days followed by analysis of alkaline phosphatase (ALP) activity by densitometry using the Revelation Program (Dynex Tech, Chantilly, Va., USA) and the methods described previously Liao et al., 2008] . Cells (1 ! 10 4 ) were plated in 24-well plates and then grown to 80% confluence before introduction of ALP induction media; each sample was run three independent times in triplicate.
Osteogenic Differentiation SSEA-4+ cells (1 ! 10 4 ) were plated onto 24-well collagencoated plates, allowed to reach 80% confluence, and then incubated in an osteogenic medium. Osteogenesis induction medium contained: ␣ -minimum essential medium ( ␣ -MEM; Invitrogen), 5% FBS, 1% P/S, 10 m M Na-␤ -glycerophosphate (Sigma), 0.2 m M ascorbic acid phosphate, and 10 -8 M dexamethasone. Cells were stained with Alizarin Red S (Sigma) at 25 days after plating in osteogenic medium. Each sample was run three independent times in triplicate. To quantify the level of calcium deposited by the cells, deposited Alizarin Red S was extracted by 10% cetylpyridinium chloride in distilled water and assessed for absorbance at 560 nm. To further confirm the osteogenic potential of the ADSC, a different set of cells processed similarly, except for staining with Alizarin Red S, were collected for osteogenic gene expression analysis.
Adipogenic Differentiation
Breast adipose-derived SSEA-4+ cells were stained with Oil Red O (Sigma) at 18 days after plating in adipogenic medium. Adipogenesis induction medium contained: DMEM, 10% FBS, 1% P/S, 0.5 m M 3-isobutyl-1-methylxanthine (IBMX), 1 M indomethacin, 1 M dexamethasone, and 1 M insulin (all from Sigma). Cells (1 ! 10 4 ) were plated in 24-well plates and cultured to 80% confluence before introduction of adipogenesis induction media. Each sample was run three independent times in triplicate. Oil Red O was extracted with 100% isopropanol and its absorbance was determined at 490 nm to assess the level of fat deposit. To further confirm the adipogenic potential of the ADSCs, cells were collected for adipogenic gene expression analysis following culture in adipogenic differentiation medium.
Gene Expression Analysis
Gene expression analysis was performed as described previously Liao et al., 2008] . Briefly, total RNA was extracted from 1 ! 10 6 breast adipose-derived SSEA-4+ sorted cells either cultured in osteogenic medium or maintained in regular maintenance medium using Trizol following the manufacturer's protocol. The mRNA was reverse transcribed to cDNA using a SuperScript TM First-Strand Synthesis System for RT-PCR according to the manufacturer's instructions. cDNA was amplified using an Eppendorf PCR System at 94 ° C for 30 s, 65 ° C for 30 s, and 72 ° C for 1 min for 30 or 35 cycles after initial denaturation at 94 ° C for 5 min. All primer sequences for the osteogenic or adipogenic genes that were used were determined using established GenBank sequences and are indicated in table 1 . PCR fragments were analyzed by agarose gel electrophoresis. Gene expression analysis was performed a minimum of three independent times per sample. Triplicate PCR reactions were amplified using primers designed for ␤ -actin as a control for assessing PCR efficiency.
Statistical Analysis
Data are expressed as means 8 SD. Statistical analyses were performed using Student's t test and one-way or two-way analysis of variance followed by post hoc multiple comparison testing. p ! 0.05 was considered statistically significant. Experiments were done in triplicate and at least three separate times.
Results
Isolation of ADSCs
The cells isolated from breast and abdominal adipose tissues were assessed for selected marker expression either immediately after isolation prior to plating or after plating and passaging. The major focus was on SSEA-4 expression, but other surface antigens examined were: CD45, CD49a, CD105, and CD146. Figure 1 a, b shows the morphological appearance of cells isolated from breast and abdominal adipose tissues, respectively. The expression profile of selected surface antigens by cells isolated from breast and abdominal adipose tissues is shown in figure  1 c, d , respectively. Table 2 shows the expression levels of each antigen at different passages in cells isolated from breast tissue. The results show that, prior to plating, the level of cells expressing SSEA-4 in cells isolated from breast tissue on average was 12%. Upon passaging, which removed most of the nonadherent cells, the level of SSEA-4+ cells in adipose-derived cells from breast tissue averaged 48% of the adherent cells whereas in cells harvested from abdominal fat, SSEA-4-expressing cells averaged 12% ( table 2 ) based on the adipose tissue harvested from 3 patients. With extended culturing, there was a slight increase in SSEA-4-expressing cells from breast abdominal tissues up to 27% at passage 5 while those from adipose tissue remained relatively constant at 45% on the average ( table 2 ) . These data suggest that a higher number of adherent cells isolated from breast adipose tissue expressed SSEA-4 while adherent cells harvested from abdominal fat tissue contained fewer cells expressing SSEA-4. This level of expression was consistent for the cells isolated from three different breast and abdominal adipose tissue donors. These data indicate that adipose tissues are enriched in cells expressing SSEA-4 but that breast adipose tissue is highly enriched in cells expressing this antigen.
Sorting of Cells Expressing SSEA-4
Cells isolated from breast and abdominal tissues were sorted using MACS based on SSEA-4 expression. Because breast tissue contained a high level of these cells and abdominal-and breast-derived cells behaved similarly, we focused on cells isolated from this tissue in comparison to the mixed population. Figure 2 a shows a bright-field image of the morphological appearance of cells sorted for SSEA-4. The sorted cell population exhibited a short and spindly morphological appearance ( fig. 2 a) . To demonstrate that the cells were positive for SSEA-4, they were immunostained for SSEA-4 expression. Following sorting for SSEA-4, 90% of the cells expressed SSEA-4 as evidenced by immunofluorescence staining ( fig. 2 b-d) . Sorted cells that were not treated with primary antibody but received secondary antibody to SSEA-4 did not show any immunofluorescence staining ( fig. 2 e) . These data ␤-Actin F5-ACC ATG GAT GAT GAT ATC GCC-3 R5-GTG CCA GAT TTT CTC CAT GTC-3 demonstrate that cells sorted based on SSEA-4 expression were positive for SSEA-4.
Differentiation of SSEA-4-Expressing Cells
Breast-derived sorted cells expressing SSEA-4 were assessed for differentiation toward osteogenic and adipogenic cell lineages. First, cells were analyzed for ALP expression in vitro following BMP-2 treatment. Results showed that SSEA-4-sorted cells from abdominal and breast adipose tissue expressed higher levels of ALP activity upon treatment with BMP-2 ( fig. 3 a, b) . Interestingly, SSEA-4+ cells expressed higher levels of ALP activity (1.75 ! higher) than did the mixed population ( fig. 3 a, b) . These data suggested that SSEA-4+ cells respond to BMP-2 efficiently to differentiate toward an osteoblast lineage.
Next, SSEA-4+-sorted and unsorted cells from breast tissues were assessed for their ability to differentiate into osteoblasts and adipocytes when cultured in respective media for 21 days. The results showed that SSEA-4+ cells deposited higher levels of calcium (6 ! higher) than the unsorted population, consistent with ALP activity results ( fig. 4 a) . Similarly, breast adipose-derived cells sorted for SSEA-4 expression were more efficient in differentiating toward an adipogenic lineage than the mixed population ( fig. 4 b) . Abdominal derived SSEA-4-sorted cells showed findings similar to those from breast-derived cells and therefore they are not reported here.
Calcium deposition was quantified indirectly by determining the level of Alizarin Red S deposition. Similarly, the adipogenic level was assessed by determining the level of ADSCs sorted for SSEA-4 were treated with or without BMP-2, and ALP activity was assessed at 3 days following treatment. In all cases, ADSCs treated with BMP-2 showed significant increases in ALP activity compared to non-BMP-2-treated cells. Cells enriched in SSEA-4 expressed higher levels of ALP activity than did the mixed cell population for both the breast-derived ADSCs ( a ) and the abdominal-derived ADSCs ( b ). The data is from 3 patients, and the experiment was performed three times. Data are expressed as means 8 SD. p ! 0.05. * Indicates statistically significant differences. ( fig. 5 a, c) . Osteogenic and adipogenic gene expression was assessed to confirm osteogenic and adipogenic differentiation. Semiquantitative PCR was used to assess osteoblast-and adipogenic-related genes; quantitative PCR was not performed ( fig. 5 b, d ) because the focus was not to quantitate gene expression but to confirm differentiation of the cells to respective lineages. The results showed expression of genes associated with osteoblasts and adipocyte differentiation ( fig. 5 b, d ).
Discussion
MSCs have great potential in regenerative medicine. Clinical trials with adult-derived stem cells have demonstrated promising results in ameliorating effects of Parkinson's disease, Crohn's disease, and congestive heart failure [Segers and Lee, 2008; Garcia-Olmo et al., 2009; Ko et al., 2010; Lindvall and Kokaia, 2010] . The therapeutic effects of MSCs are presently attributed in part to trophic factors generated by the cells that modulate the microenvironment for tissue repair [Gnecchi et al., 2005; Caplan, 2007] . The data presented here have demonstrated that the SSEA-4+ cell population has a higher potential for differentiation toward osteoblasts and adipocytes, at least in vitro. Present MSC therapies have focused on using BMSCs; however, MSCs may be derived from alternate sources. Adipose tissue has become an appealing source of stem cells as it is abundant and can be quickly and easily harvested. ADSCs have been shown to exhibit characteristics similar to those of BMSCs; the present data, however, suggest that adipose-derived MSCs are more enriched in SSEA-4-expressing cells than marrowderived MSCs [Gang et al., 2007] .
Initial studies on SSEA-4 as a marker of BMSCs suggested that this antigen was a potential marker for MSCs [Gang et al., 2007] . The level of cells expressing this antigen was, however, very low and was estimated to be at about 2% upon initial isolation. Present findings, however, have demonstrated that cells expressing this antigen are abundant upon initial isolation from adipose tissue. After the first passage there was a slight increase in cells expressing this antigen from abdominal tissue, but those from breast tissue expressing this antigen remained relatively constant. These data are, however, contrary to those of Gang et al. [2007] who showed increased expression of SSEA-4-expressing cells with extended culturing of marrow-derived cells. The present findings demonstrated that breast adipose tissue is enriched in cells expressing SSEA-4 and that the level of cells expressing this antigen remained relatively constant with culturing. Interestingly, though, upon differentiation, expression of this antigen was lost, suggesting that SSEA-4 marks a subset of cell populations within adipose tissue that exhibit MSC characteristics with a higher potential for differentiation toward osteogenic and adipogenic cell lineages.
SSEA-4 is an early embryonic cell surface antigen commonly used to identify human ESCs. Other reports have shown expression of SSEA-4 by cells in marmoset testes at 9%, in fetal marrow at 2.5%, and by cells in marrow, skin, and adipose at 7, 8, and 4%, respectively [Gang et al., 2007; Riekstina et al., 2009] . These levels are much lower than what we have shown in breast adipose tissue in which about 50% adherent cells express this antigen. It is tempting to speculate that cells expressing SSEA-4 would be more primitive than cells that do not express SSEA-4. Indeed some studies have shown that adult-derived stem cells which express SSEA-4 also express ESC markers like Oct-4 or nanog [Villadsen et al., 2007; Trubiani et al., 2010] .
Breast tissue is comprised of many cell types including cells that express SSEA-4 which are present within the ducts. The SSEA-4-positive cells in breast ducts have been described as stem cells that give rise to epithelial cells [Wojakowski et al., 2009] . It is not clear if the population of cells expressing SSEA-4 isolated from breast adipose tissue is contaminated with this cell population. This is unlikely because SSEA-4-expressing cells present in breast ducts represent a small population. In addition, following sorting, cells expressing SSEA-4 were spindle shaped, which is a characteristic of MSCs; SSEA-4+ cells also expressed high levels of MSC markers CD44, CD49a, and CD105. It is possible that epithelial mesenchymal transition could account for the presence of cells with MSC characteristics expressing SSEA-4 in breast tissue. This is, however, unlikely because this phenomenon occurs during pathological conditions [Kalluri and Weinberg, 2009 ]; the adipose tissues used for harvesting MSCs were from normal individuals. Cells expressing SSEA-4 increased in culture during expansion; this observation suggests that culture conditions could be responsible for the increase in cells expressing this antigen. This is a possibility; however, after passage 1, expression of this antigen was relatively constant, suggesting culture conditions were not responsible for the expression of this antigen by the cells. Hematopoietic stem cells express SSEA-4, and these cells are removed during media changes; FACS analysis data showed that these cells were eliminated by passage 1, indicating that adherent cells are free of CD4-expressing cells; thus SSEA-4 is expressed by a subpopulation of MSCs.
Taken together, the SSEA-4 antigen appears to mark a subset of cells of MSCs with a higher potential for differentiation toward osteogenic and adipogenic cell lineages, at least in vitro.
